A novel homozygous disruptive
PRF1
variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2
Pediatr Hematol Oncol
.
2021 Mar;38(2):174-178.
doi: 10.1080/08880018.2020.1793849.
Epub 2020 Jul 22.
Authors
F Saettini
1
,
I Castelli
1
,
M Provenzi
2
,
G Fazio
3
,
M Quadri
3
,
G Cazzaniga
3
4
,
S Sala
3
,
F Dell'Acqua
1
,
E Sieni
5
,
M L Coniglio
5
,
L Pezzoli
6
,
M Iascone
6
,
F Vendemini
1
,
A C Balduzzi
1
,
A Biondi
1
3
,
C Rizzari
1
,
S Bonanomi
1
Affiliations
1
Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
2
Pediatric Unit, Hospital Papa Giovanni XXIII, Bergamo, Italy.
3
Centro Ricerca Tettamanti, University of Milan Bicocca, Monza, Italy.
4
Department of Medicine and Surgery, University of Milan Bicocca, Monza, Italy.
5
Department of Paediatric Oncohematology, Meyer Children's University Hospital, Florence, Italy.
6
Molecular Genetics Laboratory, USSD LGM, Papa Giovanni XXIII Hospital, Bergamo, Italy.
PMID:
32696691
DOI:
10.1080/08880018.2020.1793849
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Disease Progression
Humans
Infant
Lymphohistiocytosis, Hemophagocytic / genetics*
Lymphohistiocytosis, Hemophagocytic / pathology
Male
Perforin / metabolism*
Substances
PRF1 protein, human
Perforin